ATLASBio-Rad Laboratories (BIO) earnings date: Nov 4, 2026
Bio-Rad Laboratories (BIO) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 4, 2026, after the close. Analysts expect EPS of $2.61.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on BIO
| Last price | $372.18 (-3.2%) |
|---|---|
| Normal 1-day range (±1σ) | ±1.9% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Bio-Rad Laboratories stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Bio-Rad Laboratories reports on Nov 4, 2026. One email the day before, with ATLAS’s read on Bio-Rad Laboratories. You can switch it off at any time.
Alert me before BIO reportsFree to start. Creating an account takes under a minute.
BIO earnings at a glance
| Next report (confirmed) | Wed, Nov 4, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | $2.61 |
| Last report | Aug 4, 2026 · Beat |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +20.8% |
| Average move around a report | ±9.0% (last 5) |
| Sector | Healthcare · Medical Devices |
Bio-Rad Laboratories earnings history: last 5 reports
Bio-Rad Laboratories last reported on Aug 4, 2026: EPS of $2.62 against an estimate of $1.75 (+49.7% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 4, 2026 | $1.75 | $2.62 | +49.7% | Beat | +3.9% |
| Apr 30, 2026 | $1.99 | $1.89 | -5.0% | Miss | -6.8% |
| Feb 12, 2026 | $2.70 | $2.51 | -7.0% | Miss | -12.6% |
| Oct 29, 2025 | $1.93 | $2.26 | +17.1% | Beat | -7.8% |
| Jul 31, 2025 | $1.75 | $2.61 | +49.1% | Beat | +13.8% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for BIO
See the fair value, the probability range and the earnings history of Bio-Rad Laboratories on its ATLAS page.
Bio-Rad Laboratories (BIO) stock analysisPlans from €3.99 a month.
Bio-Rad Laboratories earnings: frequently asked questions
When does Bio-Rad Laboratories (BIO) report earnings?
Bio-Rad Laboratories is scheduled to report on Wednesday, November 4, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for BIO?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is $2.61 per share (USD). Estimates can change before the report.
How often does BIO beat earnings estimates?
Of its last 5 reports with a recorded result, Bio-Rad Laboratories beat the EPS estimate 3 times; the average surprise was +20.8%. Past results do not predict the next one.
How much does BIO move around earnings?
Over its last 5 reports the stock moved an average of 9.0% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Bio-Rad Laboratories beat earnings estimates last quarter?
Bio-Rad Laboratories last reported on Aug 4, 2026: EPS of $2.62 against an estimate of $1.75 (+49.7% surprise), a beat.
How much does BIO usually move in a day?
On a normal trading day the ATLAS model puts BIO’s one-day range at about ±1.9%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 4, 2026
Educational information, not investment advice. Disclaimer